Delarocque-Astagneau Elisabeth, Baffoy Nadège, Thiers Valérie, Simon Nicole, de Valk Henriette, Laperche Syria, Couroucé Anne-Marie, Astagneau Pascal, Buisson Claude, Desenclos Jean-Claude
Institut de Veille Sanitaire, Paris, France.
Infect Control Hosp Epidemiol. 2002 Jun;23(6):328-34. doi: 10.1086/502060.
To identify the routes of transmission during an outbreak of infection with hepatitis C virus (HCV) genotype 2a/2c in a hemodialysis unit.
A matched case-control study was conducted to identify risk factors for HCV seroconversion. Direct observation and staff interviews were conducted to assess infection control practices. Molecular methods were used in a comparison of HCV infecting isolates from the case-patients and from patients infected with the 2a/2c genotype before admission to the unit.
A hemodialysis unit treating an average of 90 patients.
A case-patient was defined as a patient receiving hemodialysis with a seroconversion for HCV genotype 2a/2c between January 1994 and July 1997 who had received dialysis in the unit during the 3 months before the onset of disease. For each case-patient, 3 control-patients were randomly selected among all susceptible patients treated in the unit during the presumed contamination period of the case-patient.
HCV seroconversion was associated with the number of hemodialysis sessions undergone on a machine shared with (odds ratio [OR] per additional session, 1.3; 95% confidence interval [CI95], 0.9 to 1.8) or in the same room as (OR per additional session, 1.1; CI95, 1.0 to 1.2) a patient who was anti-HCV (genotype 2a/2c) positive. We observed several breaches in infection control procedures. Wetting of transducer protectors in the external pressure tubing sets with patient blood reflux was observed, leading to a potential contamination by blood of the pressure-sensing port of the machine, which is not accessible to routine disinfection. The molecular analysis of HCV infecting isolates identified among the case-patients revealed two groups of identical isolates similar to those of two patients infected before admission to the unit.
The results suggest patient-to-patient transmission of HCV by breaches in infection control practices and possible contamination of the machine. No additional cases have occurred since the reinforcement of infection control procedures and the use of a second transducer protector.
确定在一家血液透析单位爆发的丙型肝炎病毒(HCV)2a/2c基因型感染期间的传播途径。
进行了一项匹配病例对照研究,以确定HCV血清转化的危险因素。通过直接观察和对工作人员进行访谈来评估感染控制措施。采用分子方法比较病例患者和该单位入院前感染2a/2c基因型的患者的HCV感染分离株。
一家平均治疗90名患者的血液透析单位。
病例患者定义为1994年1月至1997年7月期间接受血液透析且HCV 2a/2c基因型血清转化、在疾病发作前3个月内在该单位接受透析的患者。对于每例病例患者,在病例患者假定的污染期内在该单位接受治疗的所有易感患者中随机选择3名对照患者。
HCV血清转化与在与抗-HCV(基因型2a/2c)阳性患者共用的机器上(每增加一次透析疗程的比值比[OR]为1.3;95%置信区间[CI95]为0.9至1.8)或在同一房间内(每增加一次透析疗程的OR为1.1;CI95为1.0至1.2)进行的血液透析疗程数有关。我们观察到感染控制程序存在几处漏洞。观察到外部压力管路装置中的传感器保护器因患者血液回流而被浸湿,导致机器压力传感端口有被血液污染的潜在风险,而该端口无法进行常规消毒。对病例患者中鉴定出的HCV感染分离株进行分子分析,发现两组相同的分离株,与该单位入院前感染的两名患者的分离株相似。
结果表明,感染控制措施的漏洞导致HCV在患者之间传播以及机器可能受到污染。自加强感染控制措施并使用第二个传感器保护器以来,未再发生其他病例。